IFN-β systemic treatment for 7 days dramatically reversed the decreased leukocyte adhesion and rolling in the U87 glioma graft, while tortuous vessel morphology and red blood cell velocity were not unchanged (Table II). This evidence concerns the gene IFNB1 and glioma.